These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7594669)
21. Efficacy of intravitreal administrations of linezolid in an experimental model of S. aureus-related endophthalmitis. Saleh M; Lefèvre S; Acar N; Bourcier T; Marcellin L; Prévost G; Subilia A; Gaucher D; Jehl F Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4832-41. PubMed ID: 22661478 [TBL] [Abstract][Full Text] [Related]
22. Prevention of Staphylococcus aureus endophthalmitis with topical gatifloxacin in a rabbit prophylaxis model. de Castro LE; Sandoval HP; Bartholomew LR; Vroman DT; Solomon KD J Ocul Pharmacol Ther; 2006 Apr; 22(2):132-8. PubMed ID: 16722799 [TBL] [Abstract][Full Text] [Related]
23. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis. Kim JY; Kim SY Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530 [TBL] [Abstract][Full Text] [Related]
24. Treatment of experimental methicillin-resistant Staphylococcus epidermidis endophthalmitis with intravitreal vancomycin and intravitreal dexamethasone. Smith MA; Sorenson JA; D'Aversa G; Mandelbaum S; Udell I; Harrison W J Infect Dis; 1997 Feb; 175(2):462-6. PubMed ID: 9203674 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic efficacy of intravitreal ceftazidime, imipenem, and amikacin in a swine model of posttraumatic Pseudomonas aeruginosa endophthalmitis. Ng EW; D'Amico DT Retina; 1997; 17(5):464-5. PubMed ID: 9355203 [No Abstract] [Full Text] [Related]
26. Prophylactic effect of topical fluoroquinolones in a rabbit model of Staphylococcus aureus endophthalmitis. Wu X; Chen H; Jiang H; Xu Y; Liu T; Xu L J Ocul Pharmacol Ther; 2012 Apr; 28(2):186-93. PubMed ID: 22077488 [TBL] [Abstract][Full Text] [Related]
27. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis. Haugen B; Werner L; Romaniv N; Haymore J; Kleinmann G; Mamalis N; Olson RJ J Cataract Refract Surg; 2008 May; 34(5):853-8. PubMed ID: 18471646 [TBL] [Abstract][Full Text] [Related]
29. Staphylococcus aureus and its Bearing on Ophthalmic Disease. Sadaka A; Durand ML; Sisk R; Gilmore MS Ocul Immunol Inflamm; 2017 Feb; 25(1):111-121. PubMed ID: 26679534 [TBL] [Abstract][Full Text] [Related]
30. Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients. Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega FM J Exp Clin Cancer Res; 1997 Sep; 16(3):321-4. PubMed ID: 9387908 [TBL] [Abstract][Full Text] [Related]
31. Controlled clinical trial of pefloxacin versus imipenem in severe acute pancreatitis. Bassi C; Falconi M; Talamini G; Uomo G; Papaccio G; Dervenis C; Salvia R; Minelli EB; Pederzoli P Gastroenterology; 1998 Dec; 115(6):1513-7. PubMed ID: 9834279 [TBL] [Abstract][Full Text] [Related]
32. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model. Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872 [TBL] [Abstract][Full Text] [Related]
33. Prophylaxis of endophthalmitis. Peyman GA; Daun M Ophthalmic Surg; 1994; 25(10):671-4. PubMed ID: 7898858 [TBL] [Abstract][Full Text] [Related]
34. Role of protein D2 and lipopolysaccharide in diffusion of quinolones through the outer membrane of Pseudomonas aeruginosa. Michéa-Hamzehpour M; Furet YX; Pechère JC Antimicrob Agents Chemother; 1991 Oct; 35(10):2091-7. PubMed ID: 1662023 [TBL] [Abstract][Full Text] [Related]
35. Comparison of intravitreal vancomycin and daptomycin application in experimental methicillin-resistant Staphylococcus aureus (MRSA) endophthalmitis in rabbits. Coskun E; Okumus S; Gurler B; Demir T; Bahar AY; Zer Y; Comez A; Tatar MG; Aksoy U; Erbagci I Cutan Ocul Toxicol; 2013 Sep; 32(3):222-7. PubMed ID: 23368969 [TBL] [Abstract][Full Text] [Related]
36. The role of topical antibiotic prophylaxis to prevent endophthalmitis after intravitreal injection. Storey P; Dollin M; Pitcher J; Reddy S; Vojtko J; Vander J; Hsu J; Garg SJ; Ophthalmology; 2014 Jan; 121(1):283-289. PubMed ID: 24144453 [TBL] [Abstract][Full Text] [Related]
37. Subconjunctival delivery of antibiotics in a controlled-release system: a novel anti-infective prophylaxis approach for cataract surgery. Cardillo JA; Paganelli F; Melo LA; Silva AA; Pizzolitto AC; Oliveira AG; Arch Ophthalmol; 2010 Jan; 128(1):81-7. PubMed ID: 20065222 [TBL] [Abstract][Full Text] [Related]
38. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents. Ishag AJ; Durgham SM; Shibl AM Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333 [TBL] [Abstract][Full Text] [Related]